Tracked deals
8
8 tracked deals across 2017-2024.
Operating Company
Healthcare
Eurofins Clinical Testing Lux
Luxembourg, Luxembourg, Luxembourg
Eurofins clinical testing entity within Eurofins’ global clinical diagnostics network.
- Focus Areas
- Clinical diagnostics laboratory services, Genetic testing, Molecular / NGS diagnostics
- Website
- eurofins.com
Recent pace
0
0 tracked deals announced in the last 12 months.
Deal mix
Buyout
8 buyout
Eurofins Clinical Testing Lux Acquisition Volume by Year
Last 4 years
Supporting Data
Recent Transactions
-
- Buyer
- Eurofins Scientific
- Target
- SYNLAB’s clinical diagnostics operations in Spain
- Seller
- SYNLAB
- Industry
- Healthcare Services
- Location
- Spain
- Type
- Buyout
Eurofins Scientific has reached an agreement with SYNLAB to acquire SYNLAB’s clinical diagnostics operations in Spain. The deal is subject to regulatory approvals and is expected to close in 2025.
-
September 16, 2024
- Buyer
- Eurofins Scientific
- Target
- Infinity Laboratories, Inc.
- Industry
- Healthcare Services
- Location
- Pennsylvania, United States
- Type
- Buyout
Eurofins Scientific has completed the acquisition of Infinity Laboratories, a U.S.-based contract testing group that operates eight laboratories and employs approximately 100 staff. The deal expands Eurofins' microbiology and package testing footprint across the United States, enhancing its BioPharma and Medical Device testing capabilities and geographic coverage.
-
August 12, 2022
- Buyer
- Eurofins Scientific
- Target
- QSAI Analysis and Research Center Co.,Ltd. (QARC)
- Industry
- Healthcare Services
- Location
- Japan
- Type
- Buyout
Eurofins Scientific has signed an agreement to acquire a majority stake in QSAI Analysis and Research Center Co., Ltd. (QARC). QARC is a leading private pesticide testing laboratory in Japan offering more than 800 pesticide screening tests and related food testing services.
-
February 9, 2022
- Buyer
- Eurofins Scientific SE, Eurofins Clinical Testing Lux Sarl
- Target
- Genetic Testing Service JSC (Gentis)
- Industry
- Healthcare Services
- Location
- Hanoi, Vietnam
- Type
- Buyout
Eurofins Scientific, through its subsidiary Eurofins Clinical Testing Lux Sarl, has acquired Genetic Testing Service JSC (Gentis), a market leader in specialised genetic testing in Vietnam. The deal expands Eurofins' footprint in Southeast Asia and strengthens its clinical genetics and advanced molecular diagnostics capabilities in the region.
-
December 10, 2021
- Buyer
- Eurofins Scientific
- Target
- Genetic Lab Co.,Ltd. (Genetic Lab, “G Lab”)
- Seller
- Transgenic Inc.
- Industry
- Healthcare Services
- Location
- Japan
- Type
- Buyout
Eurofins Scientific has entered into a share purchase agreement to acquire Genetic Lab Co.,Ltd. (“G Lab”), a molecular biology-based testing provider in Japan. The acquisition is intended to strengthen Eurofins’ expansion in Asia and enhance its clinical and genetic testing capabilities, including COVID-19 PCR testing and biomarker development support for drug discovery and companion drugs.
-
August 4, 2021
- Buyer
- Eurofins Scientific
- Target
- bioskin GmbH
- Industry
- Healthcare Services
- Location
- Hamburg, Germany
- Type
- Buyout
Eurofins Scientific has completed the acquisition of bioskin GmbH, a Hamburg-based dermatology-focused CRO that provides clinical trials for drugs, medical devices, food supplements and advanced cosmetics. The deal expands Eurofins' clinical study management and dermatology capabilities in Germany and strengthens its Cosmetics & Personal Care testing offering.
-
- Buyer
- Eurofins Scientific, Eurofins Clinical Testing US Holdings, Inc.
- Target
- DNA Diagnostics Center (DDC)
- Seller
- GHO Capital Partners LLP (GHO Capital)
- Industry
- Biotechnology
- Location
- Ohio, United States
- Type
- Buyout
Eurofins Scientific, via its subsidiary Eurofins Clinical Testing US Holdings, has entered into an agreement to acquire DNA Diagnostics Center (DDC), a consumer-focused DNA testing laboratory. The deal is expected to expand Eurofins’ reach into consumer genetics and health & wellness markets, with DDC projected to generate over $55M in 2021 revenue and operating from its Fairfield, Ohio facility.
-
- Buyer
- Eurofins Scientific SE
- Target
- LifeCodexx AG
- Seller
- GATC Biotech AG
- Industry
- Biotechnology
- Location
- Baden-Württemberg, Germany
- Type
- Buyout
Eurofins Scientific has acquired a 62.63% stake in LifeCodexx AG from GATC Biotech AG, strengthening Eurofins' non-invasive prenatal testing (NIPT) capabilities. LifeCodexx, headquartered in Constance, Germany, is a developer of the PrenaTest NIPT and generated approximately EUR 7m in revenue in 2016.
Related Acquisition Pages
Healthcare Services Buyers & Acquisitions
6 tracked deals by Eurofins Clinical Testing Lux.
Biotechnology Buyers & Acquisitions
2 tracked deals by Eurofins Clinical Testing Lux.
Acquisitions in Ohio
1 tracked deal by Eurofins Clinical Testing Lux.
Acquisitions in Pennsylvania
1 tracked deal by Eurofins Clinical Testing Lux.
Selling a company? Get in front of buyers like Eurofins Clinical Testing Lux
Turn tracked acquisition activity into an outreach-ready buyer list.